Recombinant Human UBTD2 protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human UBTD2 protein is a Human Full Length protein, in the 1 to 234 aa range, expressed in Escherichia coli, with >95%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
DCUBP, SB72, UBTD2, Ubiquitin domain-containing protein 2, Dendritic cell-derived ubiquitin-like protein, Ubiquitin-like protein SB72, DC-UbP
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human UBTD2 protein (AB131702)
15% SDS-PAGE showing ab131702 at approximately 28.6 kDa (3µg).
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
UBTD2 regulates protein turnover by interacting with the ubiquitin-proteasome system impacting cellular stress responses. UBTD2 is part of a complex that includes other proteins such as E3 ubiquitin ligases which facilitate the tagging of proteins for degradation. This function impacts various pathways in response to cell damage or stress aiding in the maintenance of cellular health by removing misfolded or damaged proteins.
Pathways
The activity of UBTD2 fits into processes such as the cell cycle and apoptosis regulation. In the ubiquitin-proteasome pathway UBTD2 collaborates with proteins like HECTD3 an E3 ubiquitin ligase to mediate the degradation of specific proteins involved in these pathways. Its role in these processes highlights its importance in maintaining cellular homeostasis and ensuring proper cell cycle progression.
Specifications
Form
Liquid
Additional notes
ab131702 is purified using conventional chromatography techniques
General info
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com